Health & Life Sciences

Health & Life Sciences

Policy expertise in pharmaceuticals, biotechnology, medical technology, and digital health

Our seasoned team of policy advisers specialising in health and life sciences, sustainability, and retail and supply chains, help clients in these technology-enabled sectors drive and navigate policy change to deploy innovation that improves the health of people and the planet.

Product, Platform, and Disease-Specific Policy & Government Affairs: We navigate the complex landscape of policy and government affairs specific to individual products, platforms like AAV-based gene therapy and CAR-T, diseases like COPD and cervical cancer, and broader therapeutic areas from oncology to infectious disease. Our approach integrates deep political insights with a keen understanding of health and life sciences innovation to foster environments that enhance market entry and sustainability. Our expertise has been called upon for companies looking to influence laws, streamline product approvals, prepare for launch, and expand coverage. We focus on creating strategic, win-win engagements with policymakers and patients, ensuring that the interests of our clients are effectively represented and advanced.

Multistakeholder Alliances, Coalitions, and Public-Private Partnerships: Our team excels in orchestrating and leading multistakeholder alliances, coalitions, and public-private partnerships that drive forward health and life sciences policy priorities. By leveraging our extensive network across government, industry, academia, and civil society, we create synergistic collaborations that accelerate innovation and access to healthcare solutions. These partnerships can stand alone as independent initiatives or become embedded within or adjacent to multilateral forums like APEC and Summit of the Americas. They are tailored to harness collective strengths, address common challenges, and optimize outcomes in healthcare delivery and disease management, particularly in areas like rare diseases and immunization.

Market Shaping and Market Access Strategy: We are a leader in developing market shaping and access strategies that ensure the successful launch and sustained availability, accessibility, and affordability of medical innovations. Our strategic insights help clients navigate complex pricing, reimbursement, and access landscapes from a proactive, upstream, and government affairs/policy-oriented perspective. By analyzing market trends and stakeholder needs, we work with our Market Access teams to design and implement strategies that optimize product positioning, help educate payer bodies and HTA bodies, and maximize patient reach.

 

What we do

  • Shape the policies that enable your access to markets worldwide
  • Assemble and manage coalitions or partnerships to drive policy solutions
  • Navigate and drive change through multilateral organisations, including the Asia Pacific Economic Cooperation Forum, the World Health Organization (WHO), the Summit of the Americas, and the Organization of American States (OAS).

Engage with our policy experts

REQUEST MEETING

Our latest reports & articles

Advancing Responsible AI Public Sector Procurement and Adoption in ASEAN

Advancing Responsible AI Public Sector Procurement and Adoption in ASEAN

Artificial intelligence (AI) is a powerful technology that can transform the way we live, work, and interact. While it can...

2 May 2024 General
Android’s Economic and Social Impact in Mexico

Android’s Economic and Social Impact in Mexico

Mexico is one of the fastest-growing mobile economies in the region, offering a relatively young and expanding mobile market with...

26 Apr 2024 Reports
Driving Brazil’s app ecosystem: The economic impact of Google Play and Android

Driving Brazil’s app ecosystem: The economic impact of Google Play and Android

With the largest Internet population in Latin America and the fourth-largest market for app adoption globally, Brazil is an established...

15 Apr 2024 Opinion
Responsible AI Readiness Index (RARI)

Responsible AI Readiness Index (RARI)

In an era where AI increasingly influences every aspect of society, the need for responsible and ethical practices has become...

11 Apr 2024 General